ACAD
27.32
-0.47
-1.69%
AEMD
4.64
-0.03
-0.64%
APRI
1.32
+0.03
+2.33%
ARNA
1.43
-0.02
-1.38%
ATEC
4.99
-0.09
-1.77%
CNAT
1.93
+0.05
+2.6543%
CRXM
0.16
-0.01
-5.83%
CYTX
1.55
-0.01
-0.64%
DXCM
65
+0.55
+0.85%
GNMK
11.02
-0.32
-2.82%
HALO
11.445
-0.375
-3.173%
ILMN
126.18
-1.74
-1.36%
INNV
0.261
+0.003
+1.15892%
INO
7.06
-0.02
-0.28%
ISCO
1.2
+0.05
+4.35%
ISIS
0
0.00
0.00%
LGND
105.24
-1.27
-1.19%
LPTN
2.67
-0.046
-1.6972%
MBVX
4.07
-0.05
-1.21%
MEIP
1.55
-0.05
-3.13%
MNOV
7.64
+0.43
+5.96%
MRTX
5.075
-0.075
-1.456%
MSTX
0.083
-0.001
-0.9512%
NBIX
43.64
+0.03
+0.07%
NUVA
65.98
+0.12
+0.18%
ONCS
1.31
-0.05
-3.68%
ONVO
3.034
-0.066
-2.1419%
OREX
1.86
-0.04
-2.11%
OTIC
15.5
+0.35
+2.31%
QDEL
22.01
-0.01
-0.05%
RCPT
0
0.00
0.00%
RGLS
2.575
-0.275
-9.649%
RMD
59.06
-0.87
-1.45%
SCIE
0.002
+0.001
+35.7143%
SPHS
2.74
-0.06
-2.14%
SRNE
5.25
-0.05
-0.94%
TROV
2.45
-0.05
-2.00%
VICL
2.31
+0.01
+0.43%
ZGNX
13.1
+0.4
+3.15%
ACAD
27.32
-0.47
-1.69%
AEMD
4.64
-0.03
-0.64%
APRI
1.32
+0.03
+2.33%
ARNA
1.43
-0.02
-1.38%
ATEC
4.99
-0.09
-1.77%
CNAT
1.93
+0.05
+2.6543%
CRXM
0.16
-0.01
-5.83%
CYTX
1.55
-0.01
-0.64%
DXCM
65
+0.55
+0.85%
GNMK
11.02
-0.32
-2.82%
HALO
11.445
-0.375
-3.173%
ILMN
126.18
-1.74
-1.36%
INNV
0.261
+0.003
+1.15892%
INO
7.06
-0.02
-0.28%
ISCO
1.2
+0.05
+4.35%
ISIS
0
0.00
0.00%
LGND
105.24
-1.27
-1.19%
LPTN
2.67
-0.046
-1.6972%
MBVX
4.07
-0.05
-1.21%
MEIP
1.55
-0.05
-3.13%
MNOV
7.64
+0.43
+5.96%
MRTX
5.075
-0.075
-1.456%
MSTX
0.083
-0.001
-0.9512%
NBIX
43.64
+0.03
+0.07%
NUVA
65.98
+0.12
+0.18%
ONCS
1.31
-0.05
-3.68%
ONVO
3.034
-0.066
-2.1419%
OREX
1.86
-0.04
-2.11%
OTIC
15.5
+0.35
+2.31%
QDEL
22.01
-0.01
-0.05%
RCPT
0
0.00
0.00%
RGLS
2.575
-0.275
-9.649%
RMD
59.06
-0.87
-1.45%
SCIE
0.002
+0.001
+35.7143%
SPHS
2.74
-0.06
-2.14%
SRNE
5.25
-0.05
-0.94%
TROV
2.45
-0.05
-2.00%
VICL
2.31
+0.01
+0.43%
ZGNX
13.1
+0.4
+3.15%
Home » Archive by Category

Diagnostics

San Diego’s Biotechnology Companies: Who’s Taking Off?

March 8, 2012 – 9:13 am

Here at SDBN we’ve been updating our directory of 400+ San Diego biotech companies.  We were surprised to find close to 40 companies removed from the local scene – due to acquisition or shut down.  …

The Future of Personal Genetic Testing and Diagnostics with Pathway Genomics

August 26, 2011 – 9:57 am

The Pathway Genomics business model is based on bridging a gap in personalized medicine.  As Ed MacBean, their VP of Product Development, explained at SDBN’s August 16th event, in a nutshell they connect clients through …

SDBN August 16th 2011 Event Featuring Pathway Genomics

July 29, 2011 – 9:41 am

We polled you late last year about events you’d like us to have in 2011, and diagnostics was one of the top items on the list. In San Diego, we have a great atmosphere for …